Jennifer Solis
Geriatric Medicine · Live Oak, TXNPI 1679173652
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,196, more than ten times the $31 reported in 2021. Among geriatric medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 112 payments — averaging $27.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$384
- Incyte Corporation$377
- Merck$213
- Karyopharm Therapeutics Inc.$204
- Inari Medical, Inc.$173
- AstraZeneca$162
- plus $2K from 33 others
What the payments were for
- Food & beverage$3,03197%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 15 | $384 |
| Incyte Corporation | 14 | $377 |
| Merck | 10 | $213 |
| Karyopharm Therapeutics Inc. | 5 | $204 |
| Inari Medical, Inc. | 1 | $173 |
| AstraZeneca(2 entities) | 7 | $162 |
| Johnson & Johnson | 8 | $151 |
| Daiichi Sankyo Inc. | 1 | $146 |
| Pharmacosmos Therapeutics Inc. | 1 | $125 |
| Gilead | 1 | $125 |
| AbbVie | 4 | $81 |
| Bayer | 3 | $79 |
| Genentech USA, Inc. | 3 | $67 |
| Sanofi | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Sobi, Inc | 2 | $51 |
| Astellas Pharma US Inc | 2 | $48 |
| GSK | 2 | $43 |
| Geron Corporation | 2 | $40 |
| Lilly USA, LLC | 2 | $40 |
| Eisai Inc. | 2 | $39 |
| Ipsen Biopharmaceuticals, Inc | 2 | $38 |
| Spectrum Pharmaceuticals Inc. | 2 | $37 |
| Azurity Pharmaceuticals, Inc. | 2 | $36 |
| Morphosys, US Inc. | 1 | $31 |
| Jazz Pharmaceuticals Inc. | 2 | $31 |
| Bristol Myers Squibb | 1 | $29 |
| Apellis Pharmaceuticals, Inc. | 1 | $28 |
| Biomarin Pharmaceutical Inc. | 1 | $26 |
| Iovance Biotherapeutics, Inc. | 1 | $25 |
| Legend Biotech USA Inc. | 1 | $25 |
| Deciphera Pharmaceuticals Inc. | 1 | $25 |
| Puma Biotechnology, Inc. | 1 | $23 |
| EMD Serono, Inc. | 1 | $21 |
| AVEO Pharmaceuticals, Inc. | 1 | $20 |
| Rigel Pharmaceuticals, Inc. | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $19 |
| Tersera Therapeutics LLC | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$173
- CT THROMBECTOMY SYSTEM KIT$173
- Enhertu$146
- Monoferric$125
- XPOVIO$125
How this compares
$3,131 in reported general payments places this provider in the 90th percentile of 275 geriatric medicine providers in Texas.
Other geriatric medicine in Live Oak
- Mauricio Gonzalez-AriasAustin$825K
- Eberenne IgbokwePearland$124K
- Diana KerwinDallas$81K
- David SmithBrownwood$19K
- Alejandro ArizmendiHelotes$15K
- Rosa VizcarraSan Antonio$9K
- George TaffetHouston$9K
- John CarrollCorpus Christi$8K
- Santos SoberonBeaumont$7K
- Sunitha AlexanderThe Woodlands$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.